Make an Appointment
-
Leila Khorasani, MD1959 Ne Pacific Street, C-212 Box 356340, Seattle, WA 98195 map
-
Virginia Mason Medical Center1100 9th Avenue, Seattle, WA 98101 map
Dr. Leila Khorasani is a neurosurgeon in Seattle. She provides surgical treatments for a range of conditions affecting the nervous system, such as epilepsy and Parkinson's disease.
Leila Khorasani, MD
Accepting New Patients?
Yes, Dr. Leila Khorasani is accepting new patients at this office.
Phone
Address
1959 Ne Pacific Street, C-212 Box 356340, Seattle, WA 98195
Office Details
Virginia Mason Medical Center
Please Note: This link will direct you to a third-party website unaffiliated with MD.com (https://www.virginiamason.org/body.cfm?id=6563), where you're able to request or schedule an appointment online with Dr. Leila Khorasani.
Accepting New Patients?
Yes, Dr. Leila Khorasani is accepting new patients at this office.
Phone
Address
1100 9th Avenue, Seattle, WA 98101-2756
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Leila Khorasani graduated from Other in 2003.
Dr. Khorasani has two offices in Washington where she specializes in Neurosurgery.
Dr. Khorasani works with three hundred and eighty-four doctors including Dr. Rosalyn Pham and Dr. Gurkamal Chatta.
Specialty
-
Neurosurgery
As a neurosurgeon, Dr. Khorasani is trained to perform highly technical surgeries to correct disorders of the central, autonomic or peripheral nervous systems. She may provide both invasive and minimally-invasive surgical treatment options, depending upon the patient's condition. Neurosurgeons may treat spinal disorders, traumatic brain injuries, tumors, Parkinson's disease, and more.
Education & Training
Medical School
-
Other
MD • 2003
Hospital Affiliations
- Virginia Mason Medical Center
Languages Spoken
- English
Latest Neurosurgery News
-
Sleep, Don't Cram, Before Finals for Better GradesAmy Norton, HealthDay Reporter, Dec 10, 2018 at 12:00 PM
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
FDA Warns of Rare Stroke Risk With MS DrugRobert Preidt, Dec 5, 2018 at 2:00 PM